CG Health Ventures

Amelia Virtual Care, mental health technology company with offices in Barcelona and Mountain View, has developed the largest and most complete virtual reality platform in mental health, allowing professionals to treat a wide range of mental health disorders from common phobias to anxiety and depression. With over 60 employees and more than 200,000 VR sessions delivered, Amelia is present worldwide being the United States its main market. The new financing and management team will boost the company’s growth in this market, strengthening its commercial activity and clinical evidence.

Skingdom is a new digital e-health startup, Coachmetics aims to become the international reference in wellness coaching.

Babyscripts’ three-tiered approach to virtual maternity care allows providers to deliver risk-specific care to pregnant mothers at any time, in any place. The first tier consists of a digital education layer delivered via a mobile app, with daily gestational-age and practice-specific, customizable content extending through one year postpartum to engage and empower pregnant mothers through trusted resources. The second tier enables virtual management of pregnant patients through the addition of remote monitoring. Depending on the risk, patients are provided with medical devices (like a bluetooth-enabled blood pressure cuff) to monitor for elevated risk, alerting the provider through a unique trigger alert system to enable risk management and intervention. This smart end-to-end management of patients enables the provider to transition care outside of the clinic and address problems of access, allowing them to automate a majority of their patient care while more effectively allocating time and resources to higher-risk patients. The third tier brings the insurer into the equation in a unique collaboration between the care team and payer, solving some of the structural issues of care coordination and access to care, improving outcomes while reducing cost.

Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, with sustained improvements in blood pressure, inflammation, liver function, and BMI. Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. Founded in 2014, the company is headquartered in San Francisco, California.

S-Biomedic brings novel therapeutic solutions to the skin microbiome.The skin microbiome - a habitat of billions of beneficial and harmful bacteria - contributes to healthy skin. An imbalance of these bacteria can lead to a variety of skin conditions including acne, eczema, rosacea and ageing. S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries. They design their products using the latest advances in microbiology and dermatology. Using their technology, beneficial bacteria are selected and combined to generate products that accelerate the rebalancing of a disease microbiome. In this way, they are able to restore a healthy state back to your skin.

Genomcore, SL is a personal genomics company based in Esplugues De Llobregat, Spain, founded in 2015. The company specializes in personalized well-being, health promotion, and genetic prevention, offering services that include the collection and analysis of blood samples. Following the analysis, Genomcore provides advisory support through health coaches or genetic counselors and delivers health guides digitally and in personalized printed formats. In addition, Genomcore operates as a bioinformatics framework that emphasizes privacy and compliance, facilitating the implementation of precision healthcare in clinical settings. The company also supports the development of new protocols and services that bridge biomedical research and primary care.

Medtep is personalized medicine. They focus on disease prevention through monitoring of people's life habits. With uClinics and uPatient They aggregate and merge any kind of data (from apps, devices, sensors, etc.), so the needed information can be given in a comprehensible way to any patient through a healthcare professional. They upgrade monitoring processes to make an impact on the patient and help condition their behavior. As a response, patients learn more about their treatments and understand they are jointly responsible of their own health and welfare. They work with Pharmaceutical companies, Clinical laboratories, Medical societies, Insurance companies, Sports clubs, Patient associations, Foundations and Universities and R&D around the world.